Enliven Therapeutics, Inc.

NasdaqGS:ELVN Stock Report

Market Cap: US$1.2b

Enliven Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ELVN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 May 24SellUS$22,877,262OrbiMed Advisors LLCCompany1,033,300US$22.14
11 Apr 24SellUS$23,562,8605AM Venture Management, LLCCompany1,000,100US$24.51
14 Feb 24SellUS$12,292,5005AM Venture Management, LLCCompany825,000US$14.90
31 Jan 24SellUS$7,500,0005AM Venture Management, LLCCompany500,000US$15.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ELVN?
Owner TypeNumber of SharesOwnership Percentage
Public Companies389,4290.759%
Individual Insiders2,705,2755.27%
Hedge Funds7,302,79814.2%
VC/PE Firms11,985,86923.4%
Institutions28,946,84956.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.6%.

Top Shareholders

Top 25 shareholders own 93.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.3%
OrbiMed Advisors LLC
7,959,538US$198.0m0%2.67%
12.9%
FMR LLC
6,296,179US$156.6m10.6%0.01%
8.39%
Commodore Capital LP
4,100,000US$102.0m3.19%6.65%
8.24%
VR Adviser, LLC
4,026,331US$100.2m0%4.66%
6.56%
Fairmount Funds Management LLC
3,202,798US$79.7m0%6.28%
6.01%
BlackRock, Inc.
2,936,642US$73.1m7.54%no data
3.93%
The Vanguard Group, Inc.
1,920,372US$47.8m5.43%no data
3.59%
5AM Venture Management, LLC
1,752,174US$43.6m-32.9%8.73%
3.55%
Citadel Advisors LLC
1,733,977US$43.1m-24.9%0.04%
2.17%
RA Capital Management, L.P.
1,061,233US$26.4m-50%0.31%
2.13%
Janus Henderson Group plc
1,041,724US$25.9m43%0.01%
2.08%
Joseph Lyssikatos
1,015,188US$25.3m-5.82%no data
2.05%
Samuel Kintz
1,002,892US$25.0m-4.42%no data
1.71%
Pictet Asset Management Limited
836,324US$20.8m7.48%0.02%
1.65%
Woodline Partners LP
806,187US$20.1m11.6%0.16%
1.64%
Adage Capital Management, L.P.
800,000US$19.9m-4.76%0.03%
1.54%
Geode Capital Management, LLC
750,208US$18.7m9.94%no data
1.53%
State Street Global Advisors, Inc.
745,944US$18.6m2.9%no data
1.37%
Tavistock Life Sciences
671,358US$16.7m0%1.04%
1.33%
Polar Capital Holdings Plc
650,000US$16.2m0%0.06%
1.1%
First Turn Management, LLC
535,092US$13.3m29.5%2.11%
1.02%
Ikarian Capital, LLC
499,566US$12.4m-14.8%3.46%
1.01%
Logos Global Management, L.P.
495,000US$12.3m-16.8%1.41%
0.88%
Rock Springs Capital Management LP
428,571US$10.7m0%0.35%
0.8%
Pfizer Inc.
389,429US$9.7m0%no data